UPDATE: Citigroup Downgrades Agios Pharmaceuticals As Valuation Is Stretched

By: via Benzinga
In a report published Wednesday, Citigroup analyst Yaron Werber downgraded the rating on Agios Pharmaceuticals (NASDAQ: AGIO) from Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.